Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

Induced-fit Model

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...

Conserved Binding Sites

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...

Enzyme Kinetics

Enzyme Kinetics

Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modified Gaussian models applied to the description and deconvolution of peaks in chiral liquid chromatography.

Journal of chromatography. A·2020

Same author

Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors.

Bioorganic chemistry·2019

Same author

Fit-for-purpose chromatographic method for the determination of amikacin in human plasma for the dosage control of patients.

Talanta·2016

Same author

Fast-multivariate optimization of chiral separations in capillary electrophoresis: anticipative strategies.

Journal of chromatography. A·2014

Same author

Cyclodextrins in capillary electrophoresis: recent developments and new trends.

Journal of chromatography. A·2014

Same author

Modeling the chiral resolution ability of highly sulfated β-cyclodextrin for basic compounds in electrokinetic chromatography.

Journal of chromatography. A·2013

Search research articles

Related Experiment Video

Updated: May 19, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Experimental-like affinity constants and enantioselectivity estimates from flexible docking.

N J Gumede¹, P Singh, M I Sabela

¹Department of Chemistry, Mangosuthu University of Technology, P.O. Box 12363, Jacobs, 4026, South Africa.

Journal of Chemical Information and Modeling

|September 6, 2012

Summary

A new computational strategy accurately predicts binding affinity and enantioselectivity for drug-protein interactions, specifically warfarin with human serum albumin. This method offers a reliable alternative to experimental techniques for drug discovery.

Related Experiment Videos

Last Updated: May 19, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Area of Science:

Computational chemistry
Molecular modeling
Drug discovery

Background:

Accurate prediction of drug-protein interactions is crucial for drug development.
Experimental methods for determining binding affinity and enantioselectivity can be time-consuming and costly.
Computational approaches have limitations in predicting these properties accurately.

Purpose of the Study:

To develop and validate a novel computational strategy for predicting binding affinity and enantioselectivity.
To model the interaction between S- and R-warfarin and human serum albumin (HSA) at site I.
To provide experimental-like estimates for these crucial interaction parameters.

Main Methods:

Utilized a combined flexible modeling and docking strategy.
Included conformational search using molecular mechanics and Monte Carlo methods.
Employed rigid protein-flexible ligand docking (GlideXP) and induced fit docking.
Validated results against experimental data and analyzed intermolecular forces.

Main Results:

Achieved experimental-like affinity constants and enantioselectivity estimates.
Successfully modeled the S- and R-warfarin-HSA (site I) complexes.
Obtained an enantioselectivity factor (ES) of 1.23, consistent with literature data.
Identified hydrogen bonding and π-π interactions as key to enantioselectivity.

Conclusions:

The novel computational strategy provides accurate predictions of binding affinity and enantioselectivity.
This approach can guide drug design and reduce reliance on experimental screening.
The method offers a valuable tool for understanding drug-protein interactions.